Keyphrases
Acute Renal Failure
31%
Attenuation
62%
Cardiac Magnetic Resonance
49%
Cardiomyopathy
36%
Chamber Volume
31%
Computed Tomography
31%
Consent Documents
31%
Consent Forms
57%
Contrast Dose
39%
Coronary Angiography
31%
Counseling Quality
31%
Diastolic Dysfunction
44%
Disease-associated
35%
Echocardiographic
93%
Echocardiographic Speckle Tracking
62%
Effusion
31%
Ejection Fraction
40%
Geometric Assessment
31%
Inter-vendor Variability
31%
Intersocietal Accreditation Commission
31%
Intervendor
31%
Left Ventricular Deformation
35%
Left Ventricular Function
100%
Low-dose Radiation
31%
Mitral Annular Displacement
31%
Mitral Valve
31%
Motion Comparison
31%
Multidetector Computed Tomography
52%
Myocardial Deformation
70%
Myocardial Infarction
62%
Myocardial Perfusion
65%
Parametric Maps
31%
Pemetrexed
31%
Perfusion Abnormality
52%
Preserved Ejection Fraction
31%
Quantitative Evaluation
31%
Rapid Estimation
31%
Reduced Radiation Dose
31%
Regadenoson
52%
Relative Risk
35%
Risk Factor Management
31%
Sickle Cell Disease
93%
Speckle Tracking Echocardiography
37%
Three-dimensional (3D)
89%
Three-dimensional Echocardiography
36%
Three-dimensional Speckle Tracking Echocardiography
62%
Tube Voltage
33%
Ultra-low
31%
Vasodilator Stress
31%
Volume Deformation
31%
Medicine and Dentistry
Acute Heart Infarction
31%
Acute Kidney Injury
31%
Angina pectoris
20%
Bleeding
15%
Cardiac Magnetic Resonance Imaging
55%
Computed Tomography Angiography
31%
Computer Assisted Tomography
31%
Coronary Angiography
31%
Coronary Artery
20%
Coronary Artery Obstruction
26%
Diastolic Dysfunction
55%
Diastolic Function
31%
Dilated Cardiomyopathy
15%
Echocardiography
56%
Effusion
31%
Ejection Fraction
97%
Gadolinium
18%
Heart Left Ventricle Ejection Fraction
18%
Heart Left Ventricle Function
76%
Heart Muscle Perfusion
74%
Heart Ventricle Remodeling
31%
Informed Consent
31%
Iron Overload
18%
Left Ventricle
21%
microRNA
18%
Mitral Valve
31%
Multidetector Computed Tomography
62%
Myocardial Disease
39%
Myocardial Infarction
31%
Myocardium
26%
Patient Decision Making
31%
Patient with Sickle Cell Disease
74%
Pemetrexed
31%
Percutaneous Coronary Intervention
23%
Quality Improvement
31%
Radiation Exposure
26%
Regadenoson
62%
Reproducibility
31%
Right Ventricular Function
31%
Shared Decision Making
15%
Sickle-Cell Disease
88%
Speckle Tracking Echocardiography
37%
Stenosis
62%
Systolic Function
20%
Three Dimensional Echocardiography
39%
Three Dimensional Speckle Tracking Echocardiography
62%
Treatment Group
15%
Tricuspid Insufficiency
31%
Two Dimensional Echocardiography
18%
Two Dimensional Speckle Tracking Echocardiography
14%